Testa, M. D. | bioRxiv Science

bioRxiv2026

Global proteomic analysis of sea urchin embryos reveals dynamic changes throughout embryogenesis

The sea urchin is a long-studied model used to study fertilization and various developmental processes. While its genome and transcriptomics data are well documented, the global quantitative proteomic dynamics that complement mRNA expression during development are not available. Here we utilize an "in-cell proteomics" strategy to profile the proteomic changes in 5 developmental time points (egg, 32-cell, blastula, gastrula and larva) of the purple sea urchin, Strongylocentrotus purpuratus. This strategy bypasses cell lysis needed in conventional proteomic experiments and detects over 6,000 protein groups using only 50 eggs/embryos. Over 3,000 proteins have significant changes throughout development that cluster into 6 unique expression patterns. Analysis of signaling proteins and some transcription factors involved in cell specification and differentiation align well with published literature, supporting that proteomes obtained reflect biology of the organism. Furthermore, a majority of mRNA and their corresponding protein levels are discordantly correlated across development. Overall, this study provides a comprehensive analysis of proteomic changes occurring throughout sea urchin development and establishes a powerful and sensitive high-throughput approach suitable for detecting proteomic changes with a small number of embryos.

developmental biology↗

bioRxiv2026

mRNAbow: A versatile gene expression system for multiplexed fluorescent imaging using optimized in vitro transcribed mRNA

Messenger RNA (mRNA) transfection enables rapid, transient protein expression without nuclear entry, providing a powerful alternative to DNA or viral delivery in post-mitotic and otherwise difficult-to-transfect cells. Although in vitro transcribed (IVT) mRNAs have revolutionized therapeutic applications, their adoption in experimental biology remains limited by challenges in synthesis, variability across cell types, and concerns about cytotoxicity. Here, we define design principles that maximize IVT mRNA performance across diverse cellular and organismal systems. Through systematic comparison of capping strategies and base modifications, including N1-methyl-pseudouridine, 5-methylcytidine, and 5-methoxyuridine, we identify modifications that enhance translation while minimizing activation of cellular stress responses. Optimized transcripts drive robust protein expression within four hours, persist for up to one week, and support multiplexed expression of structurally and functionally distinct proteins in mammalian cells, including cancer cell lines, iPSC-derived systems, primary cells, and organoids, as well as in vivo in zebrafish embryos and in less genetically tractable models such as Danionella cerebrum and sea urchin embryos. To further expand accessibility for community use, we developed mRNAbow, a platform for generating low-toxicity mRNAs encoding organelle-targeted fluorescent proteins and biosensors for multiplex imaging, with corresponding plasmids made publicly available. Together, these advances establish a generalizable framework for IVT mRNA design and expand experimental access to synthetic mRNA technologies for dissecting cellular architecture and dynamics.

cell biology↗